Skip to main content
OpenTrials

Clinical trial condition

Recurrent Adult Soft Tissue Sarcoma

Explore clinical trials studying Recurrent Adult Soft Tissue Sarcoma. Study availability and eligibility vary by location and protocol.

36 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Recurrent Adult Soft Tissue Sarcoma trial results

Completed

Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma

NCT00720174

Conditions
Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor, Adult Epithelioid Sarcoma, +64 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Decatur Memorial Hospital Decatur, Illinois, United States
  • NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States
  • Ingalls Memorial Hospital Harvey, Illinois, United States
View all 13 locations
View Trial Details
Completed

Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery

NCT01623869

Conditions
Adult Angiosarcoma, Hemangiosarcoma, Neoplasms, +7 more
Locations
  • Beebe Medical Center Lewes, Delaware, United States
  • Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
  • Washington Hospital Center Washington D.C., District of Columbia, United States
  • Oncare Hawaii Inc-POB II Honolulu, Hawaii, United States
View all 70 locations
View Trial Details
Completed

Selumetinib With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery

NCT01206140

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +4 more
Locations
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View Trial Details
Completed

Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma

NCT01016015

Conditions
Metastatic Osteosarcoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
View all 24 locations
View Trial Details
Completed

Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

NCT00831844

Conditions
Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +64 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group Downey, California, United States
  • Miller Children's Hospital Long Beach, California, United States
View all 105 locations
View Trial Details
Completed

Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue Sarcoma

NCT00937495

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +4 more
Locations
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Metro-Minnesota CCOP Saint Louis Park, Minnesota, United States
View Trial Details

Related conditions